Lv41
760 积分 2025-11-29 加入
中国脱髓鞘性视神经炎靶向生物制剂治疗专家共识（2026年）
4个月前
已完结
Evaluating inebilizumab in the treatment of generalized myasthenia gravis
6个月前
已完结
中国重症肌无力研究进展近十年回顾与展望
6个月前
已完结
Unexpected pregnancy in a patient with AQP4-IgG +NMOSD after treatment with inebilizumab: a case report
7个月前
已完结
中国腱鞘巨细胞瘤临床诊疗专家共识（2025年）
7个月前
已完结
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial
9个月前
已完结
Neurological manifestations of immunoglobulin G4 related disease: a systematic review of 393 cases
9个月前
已完结
Relapse and disability outcomes in incident MOGAD patients undergoing watchful waiting after onset
9个月前
已完结
皖公网安备34019202002308
